Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sarah Mullaly"'
Autor:
Dan Barnett, Jamie Randall, Sarah Mullaly, Gail Payne, Erica Marchlik, Sheryl Krevsky Elkin, Danny Rayes, Hongkun Wang, Raymond C. Wadlow, Lindsey Tishman, Timothy L. Cannon
Publikováno v:
Journal of Clinical Oncology. 39:129-129
129 Background: KRAS and NRAS (RAS) mutations are considered driver mutations in gastrointestinal malignancies such as colorectal and pancreatic cancer. Our institution obtains broad molecular testing (commercial panels with full exon coverage of at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9efe756b61a0ee4206ca4ad621b3b26b
https://doi.org/10.1200/jco.2021.39.3_suppl.129
https://doi.org/10.1200/jco.2021.39.3_suppl.129
Autor:
Sarah Mullaly
Publikováno v:
Clinical medicine (London, England). 4(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c908853fcb8b50ffb22ee1155a89a21b
https://pubmed.ncbi.nlm.nih.gov/15139734
https://pubmed.ncbi.nlm.nih.gov/15139734
Publikováno v:
The Journal of Immunology. 184:90.3-90.3
Dysregulated mucosal CD4 Th2 cell responses are a feature of several inflammatory diseases including asthma, allergies and some forms of inflammatory bowel disease. The integrin CD103 is expressed primarily on a subset of dendritic cells (DCs) that p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4989d77d16ff1a7cd18d23481883a84d
https://doi.org/10.4049/jimmunol.184.supp.90.3
https://doi.org/10.4049/jimmunol.184.supp.90.3
Autor:
Donna M Easton, Shuhua Ma, Neeloffer Mookherjee, Pamela Hamill, David Lynn, Jennifer Gardy, Sarah Mullaly, Sandra Pilat, Matthew Waldbrook, Lisa Thorson, Reza Falsafi, Avinash Chikatamarla, InnateDB Team, Louis Schofield, Brett Finlay, Fiona Brinkman, Robert EW Hancock
Publikováno v:
The Journal of Immunology. 182:134.45-134.45
Cationic host defence (antimicrobial) peptides, e.g. cathelicidin LL-37, have a variety of immunomodulatory activities that favour the safe resolution of infections. We have studied novel synthetic cationic innate defence regulator peptides that are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9519e74951fc85cb6bdf9532e3c118c
https://doi.org/10.4049/jimmunol.182.supp.134.45
https://doi.org/10.4049/jimmunol.182.supp.134.45